A Phase 1, Multinational Study of MCLA-117 in Acute Myelogenous Leukemia
MD Anderson Study Status
MCLA-117 bispecific antibody
This is a First-in-Human, single arm, open-label, multi-national study designed to determine the safety, tolerability and preliminary efficacy of MCLA 117.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Acute Myelogenous Leukemia, Acute Myeloid Leukemia
For general questions about clinical trials:
Help us #endcancer
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.